Insider Transactions in Q4 2025 at Oncology Institute, Inc. (TOI)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2025
|
Brad Hively Director |
SELL
Open market or private sale
|
Direct |
13,333
-1.91%
|
$39,999
$3.77 P/Share
|
|
Nov 20
2025
|
Mohit Kaushal Director |
BUY
Grant, award, or other acquisition
|
Direct |
91,049
+15.63%
|
-
|
|
Nov 20
2025
|
Anne Mc George Director |
BUY
Grant, award, or other acquisition
|
Direct |
108,024
+16.69%
|
-
|
|
Nov 20
2025
|
Brad Hively Director |
BUY
Grant, award, or other acquisition
|
Direct |
74,074
+5.17%
|
-
|
|
Nov 20
2025
|
Mark L Pacala Director |
BUY
Grant, award, or other acquisition
|
Direct |
81,790
+14.72%
|
-
|
|
Nov 20
2025
|
Karen Marie Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
84,877
+13.69%
|
-
|
|
Nov 20
2025
|
Gabriel Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
83,333
+11.75%
|
-
|
|
Nov 18
2025
|
Mark L Pacala Director |
SELL
Open market or private sale
|
Direct |
50,000
-7.52%
|
$200,000
$4.0 P/Share
|
|
Nov 18
2025
|
M33 Growth I L.P. Director |
SELL
Other acquisition or disposition
|
Direct |
2,500,000
-31.47%
|
-
|
|
Nov 18
2025
|
M33 Growth I L.P. Director |
BUY
Other acquisition or disposition
|
Direct |
11,818
+0.15%
|
-
|
|
Nov 18
2025
|
M33 Growth I L.P. Director |
SELL
Other acquisition or disposition
|
Indirect |
590,892
-100.0%
|
-
|
|
Nov 18
2025
|
Gabriel Ling Director |
BUY
Other acquisition or disposition
|
Direct |
141,149
+36.07%
|
-
|
|
Nov 17
2025
|
Robert Ross Carter Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
195
+0.08%
|
-
|
|
Nov 17
2025
|
Yale Podnos Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,086
+0.87%
|
-
|
|
Nov 17
2025
|
Daniel Virnich Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,464
+0.36%
|
-
|
|
Nov 12
2025
|
Yale Podnos Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,508
+0.32%
|
-
|
|
Nov 12
2025
|
Daniel Virnich Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,211
+0.35%
|
-
|